20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Complication, Postoperative in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakelyan, K; Blum, M; Bubalo, G; Dragun, D; Falck, JR; Fechner, M; Flemming, B; Gürgen, D; Haase, M; Hentschel, J; Hoff, U; Manthati, VL; Niendorf, T; Pohlmann, A; Rothe, M; Schunck, WH; Seeliger, E; Zhu, Y | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Complication, Postoperative
Article | Year |
---|---|
A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury.
Topics: 8,11,14-Eicosatrienoic Acid; Acute Kidney Injury; Animals; Cardiac Surgical Procedures; Fatty Acids; Humans; Hydroxyeicosatetraenoic Acids; Ischemia; Kidney; Male; Postoperative Complications; Rats; Rats, Inbred Lew; Reperfusion Injury; Signal Transduction | 2019 |